Coversyl AM (Aceon AM)8Mg/5 Mg – 30 tablet

$21.70

Each Coversyl AM contains 8 mg perindopril 5 mg Amlodipine 30 tablets used to treat high blood pressure, heart failure, or stable coronary artery disease

ATC Classification: C09AA04
Active Ingrediant: perindopril/Amlodipine
Generic Name: Coversyl AM
Manufacturer: Serdia
Strength: 8Mg/5 Mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 30 Tab

Examples of Packages sent

Free worldwide shipping on all orders over $50

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Coversyl AM (Aceon AM)8Mg/5 Mg – 30 tablet
$21.70

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Pronunciation

(per IN doe pril)

 

Medication Safety Issues

International issues:

The brand name Coversyl represents different salt forms of perindopril (ie, erbumine/tert-butylamine or arginine) in multiple international markets

 

Storage/Stability

Store at 20°C to 25°C (68°F to 77°F). Protect from moisture.

 

Adverse Reactions

Some reactions occurred at an incidence of >1% but ≤ placebo.

>10%:

Central nervous system: Headache (24%)

Respiratory: Cough (12%; incidence higher in women, 3:1)

1% to 10%:

Cardiovascular: Edema (4%), chest pain (2%), ECG abnormality (2%), palpitations (1%)

Central nervous system: Hypertonia (3%), sleep disorder (3%), depression (2%), paresthesia (2%), drowsiness (1%), nervousness (1%)

Dermatologic: Skin rash (2%)

Endocrine & metabolic: Increased serum triglycerides (1%), menstrual disease (1%)

Gastrointestinal: Diarrhea (4%), abdominal pain (3%), dyspepsia (2%), nausea (2%), vomiting (2%), flatulence (1%)

Genitourinary: Urinary tract infection (3%), proteinuria (2%), sexual disorder (male: 1%)

Hepatic: Increased serum ALT (2%)

Hypersensitivity: Seasonal allergy (2%)

Infection: Viral infection (3%)

Neuromuscular & skeletal: Weakness (8%), back pain (6%), leg pain (5%), arm pain (3%), arthralgia (1%), arthritis (1%), myalgia (1%), neck pain (1%)

Otic: Tinnitus (2%), otic infection (1%)

Respiratory: Upper respiratory tract infection (9%), sinusitis (5%), rhinitis (5%), pharyngitis (3%)

Miscellaneous: Fever (2%)

<1%, postmarketing, and/or case reports: Amnesia, anaphylaxis, angioedema, anxiety, arthralgia, bronchitis, bruise, cardiac conduction disturbance, cerebrovascular accident, chills, conjunctivitis, constipation, diaphoresis, dyspnea, epistaxis, erythema, facial edema, flank pain, fluid retention, gastroenteritis, gout, heart murmur, hematoma, hematuria, hyperglycemia, hypokalemia, hypotension, increased appetite, increased serum alkaline phosphatase, increased serum AST, increased serum cholesterol, increased serum creatinine, increased uric acid, leukopenia, malaise, migraine, myocardial infarction, nephrolithiasis, neutropenia, orthostatic hypotension, otalgia, pain, pruritus, psychological disorder (psychosexual disorder), pulmonary fibrosis, purpura, rhinorrhea, sneezing, syncope, tinea, urinary frequency, urinary retention, vaginitis, vasodilation, ventricular premature contractions, vertigo, visual hallucination (Doane 2013), xeroderma, xerostomia

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type